glp 1 agonist pregnancy GLP-1 Receptor Agonists in - What Physicians Need to Know? GLP-1: A Game Changer for

Glucagon-like peptide-1 receptor agonists, namely GLP-1 receptor agonists, are a class of drugs for the treatment of type 2 diabetes.

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Survodutide also reduced waist circumference, an indicator of metabolic health.

Heres what to watch as this $40B+ category continues to grow.

Shocking Truth: Compounded GLP-1s on Groupon pose serious health risks

Furthermore,...